As­traZeneca's KRAS deal with Yusen Jian­heng; Abeona gets a PDU­FA date

As­traZeneca part­ners with Chi­nese biotech: Yusen Jian­heng Bio­phar­ma­ceu­ti­cal said last week that As­traZeneca will help de­vel­op and com­mer­cial­ize a pre­clin­i­cal small …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER